Table 1 Macular thickness in both groups throughout the study
| Avastin group | NaCl group | |
| Macular thickness (μm) | Macular thickness (μm) | |
| Pre | 375.9 (76.6) | 263.2 (81.2) |
| Week 1 | 306.9 (144.8) | 295.8 (99.6) |
| Week 2 | 275.2 (81.1) | 292.3 (119.8) |
| Week 3 | 271.9 (94.7) | 282.3 (96.9) |
| Week 4 | 303.4 (164.0) | 326.5 (39.5) |
| Week 5 | 237.9 (79.2) | 367.0 (39.6) |
| Week 6 | 259.1 (116.2) | 339.3 (95.0) |
| Week 8 | 258.3 (116.7) | 374.0 (75.9) |
| Week 10 | 251.3 (81.9) | 400.8 (44.3) |
| Week 12 | 279.4 (145.9) | 314.8 (104.4) |
| Week 16 | 235.2 (69.0) | 333.8 (89.4) |
| Week 20 | 239.9 (58.9) | 339.8 (46.6) |
| Week 24 | 272.3 (91.5) | 290.8 (78.2) |
-
Pre, before infusion therapy.
